raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:90069

Systemic monochloroacetate poisoning

Type
Disease
Group
Disorder
Age of onset
All ages
Status
active

Systemic monochloroacetate poisoning is a rare, life-threatening intoxication with monochloroacetic acid (mainly through the skin, but also by inhalation or ingestion). It is characterized by vomiting, diarrhea and central nervous system (CNS)-excitability (disorientation, delirium, convulsions) as early signs of systemic poisoning, followed by CNS-depression, coma and cerebral edema. Additional signs include heart involvement (severe myocardial depression, shock, arrhythmias, nonspecific myocardial damage), severe metabolic acidosis, hypokalemia, hypocalcemia and progressive renal failure leading to anuria. Myoglobinemia and leukocytosis may occur. Manifestations may be delayed for 1-4 hours.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSystemic monochloroacetate poisoning
frIntoxication systémique au monochloroacétate
deMonochloracetat-Vergiftung, systemische
esIntoxicación sistémica por monocloroacetato
itAvvelenamento sistemico da monocloroacetato
nlSystemische monochloroacetaatvergiftiging
ptEnvenenamento sistémico por monocloroacetato
plOgólne zatrucie kwasem monochlorooctowym
csSystémová otrava monochlóracetátem
ukСистемне отруєння монохлорацетатом
zh全身性氯乙酸中毒
trSistemik monokloroasetat zehirlenmesi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10T60.3NTBTindexvalidated
ICD-11NE61NTBTattributedvalidated
MONDO0019545Evalidated
UMLSC4707283Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—EuropeClass onlyValidatedEuropean Medicines Agency 2004[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card